Experimental and Molecular Pathology: 2023, vol: 129, issue:
1)- Nan Liu, Quan-Cheng Kan, Xiao-Jian Zhang, Yu-Ming Xv, Su Zhang, Guang-Xian Zhang, Lin Zhu. Corrigendum to "Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune Encephalomyelitis." [Experimental and Molecular Pathology. 2014; 97(3):470-6. doi: 10.1016/j.yexmp.2014.10.004.].Experimental and molecular pathology. 2023, 129: 104837
3)- Li Jian-Fei, Chen Song, Feng Jun-Duo, Zhang Ming-Yu, Liu Xiao-Xia. Retraction notice to " Probucol via inhibition of NHE1 attenuates LPS-accelerated atherosclerosis and promotes plaque stability in vivo" [Experimental and Molecular Pathology 96/2 (2014) 250-256].Experimental and molecular pathology. 2023, 129: 104847
5)- Joanna Matalińska, Piotr F J Lipiński. Docking is not enough: 17-trifluoromethylphenyl trinor PGF2α is only a very weak ligand of neurokinin-1 receptor.Experimental and molecular pathology. 2023, 129: 104849
6)- Lan Luan, Nanyang Li, Keyuan Zhang, Xiaojie Wang, Hai Pan. Diversin upregulates the proliferative ability of colorectal cancer by inducing cell cycle proteins.Experimental and molecular pathology. 2023, 129: 104850